Trial Profile
Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Apr 2011
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Registrational; Therapeutic Use
- 28 Mar 2011 Additional location Panama reported in the Journal of Clinical Oncology.
- 28 Mar 2011 Results published in the Journal of Clinical Oncology.
- 24 Sep 2009 Results were presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology (ECCO-ESMO 2009).